HIV Infections Clinical Trial
Official title:
Parents Matter!: Interventions to Promote Effective Parent-Child Communication About Sex and Sexual Risk Among African American Families
Parents Matter is a community-based project whose goal it is to develop and test an intervention designed to promote effective parent-child communication about sexuality in order to promote sexual health among adolescents.
Status | Completed |
Enrollment | 2210 |
Est. completion date | September 2006 |
Est. primary completion date | September 2006 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 9 Years to 12 Years |
Eligibility |
Inclusion Criteria: The eligibility criteria for the parent-child dyad are as follows: - The parent or guardian must be African-American - The parent or guardian must be the primary caregiver for a child in 4th or 5th grade who is 12 or younger at the time of the 1st assessment. - The parent or guardian and the child must have lived together continuously for at least the past 3 years and the child must spend most nights (5 or more) with the parent or guardian. - The parent or guardian and the child must both speak English. |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label
Country | Name | City | State |
---|---|---|---|
United States | University of Georgia | Athens | Georgia |
United States | Georgia State University | Atlanta | Georgia |
United States | University of Arkansas for Medical Sciences | Little Rock | Arkansas |
Lead Sponsor | Collaborator |
---|---|
Centers for Disease Control and Prevention | University of Georgia |
United States,
Armistead, L., Clark, H., Barber, N., Dorsey, S., Hughley, J., Favors, M., & Wycoff, S. (2004). Participant retention in the Parents Matter! Program: Strategies and outcomes. Journal of Child and Family Studies, 13, 67-80.
Ball, J., Pelton, J., Forehand, R., Long, N., & Wallace, S. (2004). Methodological overview of the Parents Matter! Program St. Journal of Child and Family Studies, 13, 21-34.
Dittus, P., Miller, K.S., Kotchick, B.A., & Forehand, R. (2004). Why parents matter: The conceptual basis for a community-based HIV prevention program prevention program for African American youth. Journal of Child and Family Studies, 13, 5-20.
Forehand R, Gound M, Kotchick BA, Armistead L, Long N, Miller KS. Sexual intentions of black preadolescents: associations with risk and adaptive behaviors. Perspect Sex Reprod Health. 2005 Mar;37(1):13-8. — View Citation
Forehand, R., Miller, K.S., Armistead, L., Kitchick, B.A., & Long, N. (2004). Parents Matter! Program: An Introduction. Journal of Child and Families Studies, 13, 1-3.
Long, N., Austin, B., Gound, M., Kelly, A., Gardner, A., Dunn, R., Harris, & Miller, K. (2004). The Parents Matter! Program Interventions: Content and the facilitation process. Journal of Child and Family Studies, 13, 47-65.
Long, N., Miller, K.S., Jackson, L.C., Lindner, G.K., Hunt, R.G., Robinson, A.D., Goldsby, W.D., & Armistead, L.P. (2004). Lessons learned from the Parents Matter! Program. Journal of Child and Family Studies, 13, 101-112.
Murry, V.M., Kotchick, B.A., Wallace, S., Ketchen, B., Eddings, K., Heller, L., & Collier, I. (2004). Race, culture and ethnicity: Implications for a community intervention. Journal of Child and Family Studies, 13, 81-99.
Secrest, L.A., Lassiter, S.L., Armistead, L.P., Wyckoff, S.C., Johnson, J., Williams, W.B., & Kotchick, B.A. (2004). The Parents Matter! Program: Building a successful investigator community partnership. Journal of Child and Family Studies, 13, 35-45.
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Percent of teens who have initiated sexual intercourse at 3 years post intervention | |||
Secondary | Increase in parental knowledge at 1 year | |||
Secondary | Increase in parental skills at 1 year | |||
Secondary | Increase in parental comfort communicating at 1 year | |||
Secondary | Increase in parental confidence communicating at 1 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05454514 -
Automated Medication Platform With Video Observation and Facial Recognition to Improve Adherence to Antiretroviral Therapy in Patients With HIV/AIDS
|
N/A | |
Completed |
NCT03760458 -
The Pharmacokinetics, Safety, and Tolerability of Abacavir/Dolutegravir/Lamivudine Dispersible and Immediate Release Tablets in HIV-1-Infected Children Less Than 12 Years of Age
|
Phase 1/Phase 2 | |
Completed |
NCT03141918 -
Effect of Supplementation of Bioactive Compounds on the Energy Metabolism of People Living With HIV / AIDS
|
N/A | |
Completed |
NCT03067285 -
A Phase IV, Open-label, Randomised, Pilot Clinical Trial Designed to Evaluate the Potential Neurotoxicity of Dolutegravir/Lamivudine/Abacavir in Neurosymptomatic HIV Patients and Its Reversibility After Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide. DREAM Study
|
Phase 4 | |
Recruiting |
NCT04579146 -
Coronary Artery Disease (CAD) in Patients HIV-infected
|
||
Completed |
NCT06212531 -
Papuan Indigenous Model of Male Circumcision
|
N/A | |
Active, not recruiting |
NCT03256422 -
Antiretroviral Treatment Taken 4 Days Per Week Versus Continuous Therapy 7/7 Days Per Week in HIV-1 Infected Patients
|
Phase 3 | |
Completed |
NCT03256435 -
Retention in PrEP Care for African American MSM in Mississippi
|
N/A | |
Completed |
NCT00517803 -
Micronutrient Supplemented Probiotic Yogurt for HIV/AIDS and Other Immunodeficiencies
|
N/A | |
Active, not recruiting |
NCT03572335 -
Systems Biology of Diffusion Impairment in Human Immunodeficiency Virus (HIV)
|
||
Completed |
NCT04165200 -
Fecal Microbiota Transplantation as a Therapeutic Strategy for Patients Infected With HIV
|
N/A | |
Recruiting |
NCT03854630 -
Hepatitis B Virus Vaccination in HIV-positive Patients and Individuals at High Risk for HIV Infection
|
Phase 4 | |
Terminated |
NCT03275571 -
HIV, Computerized Depression Therapy & Cognition
|
N/A | |
Completed |
NCT02234882 -
Study on Pharmacokinetics
|
Phase 1 | |
Completed |
NCT01618305 -
Evaluating the Response to Two Antiretroviral Medication Regimens in HIV-Infected Pregnant Women, Who Begin Antiretroviral Therapy Between 20 and 36 Weeks of Pregnancy, for the Prevention of Mother-to-Child Transmission
|
Phase 4 | |
Recruiting |
NCT05043129 -
Safety and Immune Response of COVID-19 Vaccination in Patients With HIV Infection
|
||
Not yet recruiting |
NCT05536466 -
The Influence of Having Bariatric Surgery on the Pharmacokinetics, Safety and Efficacy of the Novel Non-nucleoside Reverse Transcriptase Inhibitor Doravirine
|
N/A | |
Recruiting |
NCT04985760 -
Evaluation of Trimer 4571 Therapeutic Vaccination in Adults Living With HIV on Suppressive Antiretroviral Therapy
|
Phase 1 | |
Completed |
NCT05916989 -
Stimulant Use and Methylation in HIV
|
||
Terminated |
NCT02116660 -
Evaluation of Renal Function, Efficacy, and Safety When Switching From Tenofovir/Emtricitabine Plus a Protease Inhibitor/Ritonavir, to a Combination of Raltegravir (MK-0518) Plus Nevirapine Plus Lamivudine in HIV-1 Participants With Suppressed Viremia and Impaired Renal Function (MK-0518-284)
|
Phase 2 |